Selected research
Market Structure
Global Enzymes for β-lactam Antibiotics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Enzymes for β-lactam Antibiotics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Enzymes for β-lactam Antibiotics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Enzymes for β-lactam Antibiotics include MCE, Amicogen, Biosynth, Crawford Wisdom International, Creative Enzymes, Fermenta Biotech Ltd., Merck & Co., MuseChem Chemicals and Biolab, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Enzymes for β-lactam Antibiotics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Enzymes for β-lactam Antibiotics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Enzymes for β-lactam Antibiotics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Enzymes for β-lactam Antibiotics market size, projected growth trends, production technologies, key applications, and end-use industries.
Enzymes for β-lactam Antibiotics Segment by Company
MCE
Amicogen
Biosynth
Crawford Wisdom International
Creative Enzymes
Fermenta Biotech Ltd.
Merck & Co.
MuseChem Chemicals
Biolab
Hangzhou Chuangke Biotech
Hangzhou Junfeng Bioengineering
Hunan Fulaige Biotech
Shanghai Kekai Biotech
Enzymes for β-lactam Antibiotics Segment by Type
Penicillin Acylase
β-lactamase
Other
Enzymes for β-lactam Antibiotics Segment by Application
Cephalosporins
Penicillin and Its Derivatives
Monoamide Ring
Other
Enzymes for β-lactam Antibiotics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Enzymes for β-lactam Antibiotics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Enzymes for β-lactam Antibiotics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Enzymes for β-lactam Antibiotics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Enzymes for β-lactam Antibiotics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Enzymes for β-lactam Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Enzymes for β-lactam Antibiotics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Penicillin Acylase
- β-lactamase
- Other
Applications
- Cephalosporins
- Penicillin and Its Derivatives
- Monoamide Ring
- Other
Companies covered
- MCE
- Amicogen
- Biosynth
- Crawford Wisdom International
- Creative Enzymes
- Fermenta Biotech Ltd.
- Merck & Co.
- MuseChem Chemicals
- Biolab
- Hangzhou Chuangke Biotech
- Hangzhou Junfeng Bioengineering
- Hunan Fulaige Biotech
- Shanghai Kekai Biotech
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Enzymes for β-lactam Antibiotics Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Enzymes for β-lactam Antibiotics Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Enzymes for β-lactam Antibiotics Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Enzymes for β-lactam Antibiotics Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Enzymes for β-lactam Antibiotics Market Dynamics
- 2.1 Enzymes for β-lactam Antibiotics Industry Trends
- 2.2 Enzymes for β-lactam Antibiotics Industry Drivers
- 2.3 Enzymes for β-lactam Antibiotics Industry Opportunities and Challenges
- 2.4 Enzymes for β-lactam Antibiotics Industry Restraints
3 Enzymes for β-lactam Antibiotics Market by Manufacturers
- 3.1 Global Enzymes for β-lactam Antibiotics Revenue by Manufacturers (2021-2026)
- 3.2 Global Enzymes for β-lactam Antibiotics Sales by Manufacturers (2021-2026)
- 3.3 Global Enzymes for β-lactam Antibiotics Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Enzymes for β-lactam Antibiotics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Enzymes for β-lactam Antibiotics Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Enzymes for β-lactam Antibiotics Manufacturers, Product Type & Application
- 3.7 Global Enzymes for β-lactam Antibiotics Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Enzymes for β-lactam Antibiotics Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Enzymes for β-lactam Antibiotics Players Market Share by Revenue in 2025
- 3.8.3 2025 Enzymes for β-lactam Antibiotics Tier 1, Tier 2, and Tier 3
4 Enzymes for β-lactam Antibiotics Market by Type
- 4.1 Enzymes for β-lactam Antibiotics Type Introduction
- 4.1.1 Penicillin Acylase
- 4.1.2 β-lactamase
- 4.1.3 Other
- 4.2 Global Enzymes for β-lactam Antibiotics Sales by Type
- 4.2.1 Global Enzymes for β-lactam Antibiotics Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Enzymes for β-lactam Antibiotics Sales by Type (2021-2032)
- 4.2.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Type (2021-2032)
- 4.3 Global Enzymes for β-lactam Antibiotics Revenue by Type
- 4.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Type (2021-2032)
- 4.3.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Type (2021-2032)
5 Enzymes for β-lactam Antibiotics Market by Application
- 5.1 Enzymes for β-lactam Antibiotics Application Introduction
- 5.1.1 Cephalosporins
- 5.1.2 Penicillin and Its Derivatives
- 5.1.3 Monoamide Ring
- 5.1.4 Other
- 5.2 Global Enzymes for β-lactam Antibiotics Sales by Application
- 5.2.1 Global Enzymes for β-lactam Antibiotics Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Enzymes for β-lactam Antibiotics Sales by Application (2021-2032)
- 5.2.3 Global Enzymes for β-lactam Antibiotics Sales Market Share by Application (2021-2032)
- 5.3 Global Enzymes for β-lactam Antibiotics Revenue by Application
- 5.3.1 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Enzymes for β-lactam Antibiotics Revenue by Application (2021-2032)
- 5.3.3 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Application (2021-2032)
6 Global Enzymes for β-lactam Antibiotics Sales by Region
- 6.1 Global Enzymes for β-lactam Antibiotics Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2032)
- 6.2.1 Global Enzymes for β-lactam Antibiotics Sales by Region (2021-2026)
- 6.2.2 Global Enzymes for β-lactam Antibiotics Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Enzymes for β-lactam Antibiotics Revenue by Region
- 7.1 Global Enzymes for β-lactam Antibiotics Revenue by Region
- 7.1.1 Global Enzymes for β-lactam Antibiotics Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Enzymes for β-lactam Antibiotics Revenue by Region (2021-2026)
- 7.1.3 Global Enzymes for β-lactam Antibiotics Revenue by Region (2027-2032)
- 7.1.4 Global Enzymes for β-lactam Antibiotics Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Enzymes for β-lactam Antibiotics Revenue (2021-2032)
- 7.2.2 North America Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Enzymes for β-lactam Antibiotics Revenue (2021-2032)
- 7.3.2 Europe Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Enzymes for β-lactam Antibiotics Revenue (2021-2032)
- 7.4.2 Asia-Pacific Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Enzymes for β-lactam Antibiotics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 MCE
- 8.1.1 MCE Company Information
- 8.1.2 MCE Business Overview
- 8.1.3 MCE Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 MCE Enzymes for β-lactam Antibiotics Product Portfolio
- 8.1.5 MCE Recent Developments
- 8.2 Amicogen
- 8.2.1 Amicogen Company Information
- 8.2.2 Amicogen Business Overview
- 8.2.3 Amicogen Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Amicogen Enzymes for β-lactam Antibiotics Product Portfolio
- 8.2.5 Amicogen Recent Developments
- 8.3 Biosynth
- 8.3.1 Biosynth Company Information
- 8.3.2 Biosynth Business Overview
- 8.3.3 Biosynth Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Biosynth Enzymes for β-lactam Antibiotics Product Portfolio
- 8.3.5 Biosynth Recent Developments
- 8.4 Crawford Wisdom International
- 8.4.1 Crawford Wisdom International Company Information
- 8.4.2 Crawford Wisdom International Business Overview
- 8.4.3 Crawford Wisdom International Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Crawford Wisdom International Enzymes for β-lactam Antibiotics Product Portfolio
- 8.4.5 Crawford Wisdom International Recent Developments
- 8.5 Creative Enzymes
- 8.5.1 Creative Enzymes Company Information
- 8.5.2 Creative Enzymes Business Overview
- 8.5.3 Creative Enzymes Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Creative Enzymes Enzymes for β-lactam Antibiotics Product Portfolio
- 8.5.5 Creative Enzymes Recent Developments
- 8.6 Fermenta Biotech Ltd.
- 8.6.1 Fermenta Biotech Ltd. Company Information
- 8.6.2 Fermenta Biotech Ltd. Business Overview
- 8.6.3 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fermenta Biotech Ltd. Enzymes for β-lactam Antibiotics Product Portfolio
- 8.6.5 Fermenta Biotech Ltd. Recent Developments
- 8.7 Merck & Co.
- 8.7.1 Merck & Co. Company Information
- 8.7.2 Merck & Co. Business Overview
- 8.7.3 Merck & Co. Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Merck & Co. Enzymes for β-lactam Antibiotics Product Portfolio
- 8.7.5 Merck & Co. Recent Developments
- 8.8 MuseChem Chemicals
- 8.8.1 MuseChem Chemicals Company Information
- 8.8.2 MuseChem Chemicals Business Overview
- 8.8.3 MuseChem Chemicals Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 MuseChem Chemicals Enzymes for β-lactam Antibiotics Product Portfolio
- 8.8.5 MuseChem Chemicals Recent Developments
- 8.9 Biolab
- 8.9.1 Biolab Company Information
- 8.9.2 Biolab Business Overview
- 8.9.3 Biolab Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Biolab Enzymes for β-lactam Antibiotics Product Portfolio
- 8.9.5 Biolab Recent Developments
- 8.10 Hangzhou Chuangke Biotech
- 8.10.1 Hangzhou Chuangke Biotech Company Information
- 8.10.2 Hangzhou Chuangke Biotech Business Overview
- 8.10.3 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Hangzhou Chuangke Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 8.10.5 Hangzhou Chuangke Biotech Recent Developments
- 8.11 Hangzhou Junfeng Bioengineering
- 8.11.1 Hangzhou Junfeng Bioengineering Company Information
- 8.11.2 Hangzhou Junfeng Bioengineering Business Overview
- 8.11.3 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Hangzhou Junfeng Bioengineering Enzymes for β-lactam Antibiotics Product Portfolio
- 8.11.5 Hangzhou Junfeng Bioengineering Recent Developments
- 8.12 Hunan Fulaige Biotech
- 8.12.1 Hunan Fulaige Biotech Company Information
- 8.12.2 Hunan Fulaige Biotech Business Overview
- 8.12.3 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Hunan Fulaige Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 8.12.5 Hunan Fulaige Biotech Recent Developments
- 8.13 Shanghai Kekai Biotech
- 8.13.1 Shanghai Kekai Biotech Company Information
- 8.13.2 Shanghai Kekai Biotech Business Overview
- 8.13.3 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Shanghai Kekai Biotech Enzymes for β-lactam Antibiotics Product Portfolio
- 8.13.5 Shanghai Kekai Biotech Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Enzymes for β-lactam Antibiotics Value Chain Analysis
- 9.1.1 Enzymes for β-lactam Antibiotics Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Enzymes for β-lactam Antibiotics Production Mode & Process
- 9.2 Enzymes for β-lactam Antibiotics Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Enzymes for β-lactam Antibiotics Distributors
- 9.2.3 Enzymes for β-lactam Antibiotics Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst